MedTrace Logo

Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy

NCT00002924 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 184

Last updated 2016-07-14

No results posted yet for this study

Summary

RATIONALE: Gene mutations may make prostate cancer cells unable to attach to androgens. This may permit the growth of prostate cancer. Gene testing may improve the identification of patients with advanced prostate cancer.

PURPOSE: Clinical trial to study the androgen receptor gene in patients with prostate cancer that is not responsive to hormone therapy.

Conditions

Interventions

OTHER

mutation analysis

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Alliance for Clinical Trials in Oncology

    lead OTHER

Principal Investigators

  • Mary-Ellen Taplin, MD · University of Massachusetts, Worcester

Eligibility

Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1997-01-31
Primary Completion
2006-06-30
Completion
2006-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00002924 on ClinicalTrials.gov